FeesSafety
Pluang+

Titan Builder and Phylax add transaction rule checks to Ethereum blocks to prevent rule-breaking trades.

Protocol Fundamentals
11 Nov 2026, 20:23 WIB
Tokenpost
View Source
Neutral
Titan Builder and Phylax add transaction rule checks to Ethereum blocks to prevent rule-breaking trades.

Titan Builder and Phylax have introduced a system that checks Ethereum transactions against app-defined rules before including them in blocks. This safeguard allows apps to set limits, such as capping withdrawals, and blocks transactions that violate these rules during Titan's block assembly. However, the protection only applies to blocks Titan builds and depends on apps writing relevant rules. Currently, about 53% of externally built blocks validators accept are built by Titan, with apps like Lighter and Derive using Phylax to protect nearly $1 billion in assets. While this adds a layer of security, it does not catch all exploits and lacks cryptographic proof that checks occurred, requiring users to trust Titan's process.

Phylax and Titan's new app-level checks for Ethereum blocks come as 37 of 50 major cryptocurrencies on Pluang rose today. For readers following cryptocurrency markets, here is Pluang's snapshot as of Nov 12, 2026 01:02 WIB: Ethereum (ETH) traded at Rp37.759.801 with a 2.96% gain and a Pluang order activity of 32% Sell / 68% Buy, while Chainlink (LINK) and Dogecoin (DOGE) also showed positive changes of +3.07% and +2.88% respectively.

More News

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...

Market News
Bullish
1 hour ago
Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...

Bullish
1 hour ago
Dylanex offers key Q4 inventory tips for Amazon sellers to avoid stock-outs and manage holiday demand.

Dylanex offers key Q4 inventory tips for Amazon sellers to avoid stock-outs and manage holiday demand.

Dylanex has released practical guidance for Amazon sellers to prepare inventory for the busy Q4 holiday season. The advice focuses on managing inbound shipment timing, avoiding preparation errors, planning around restock limits, and using reserve sto...

Market News
Neutral
4 hours ago
Australia project logistics market to grow to $10.27B by 2031, driven by mining and renewable energy projects

Australia project logistics market to grow to $10.27B by 2031, driven by mining and renewable energy projects

The Australia project logistics market is projected to grow from USD 7.88 billion in 2026 to USD 10.27 billion by 2031, at a CAGR of 5.52%. Growth is fueled by mining and energy projects requiring transport of oversized cargo, and expanding renewable...

Market News
Bullish
4 hours ago
Valens Semiconductor posts modest Q3 gains but ongoing losses and high costs keep sell rating intact

Valens Semiconductor posts modest Q3 gains but ongoing losses and high costs keep sell rating intact

Valens Semiconductor showed some improvement in Q3, driven by a rebound in auto sales. However, expected growth from other industries and AI applications did not materialize, weakening the optimistic outlook. The company continues to face GAAP and EB...

Company Fundamentals
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App